Remove Document Remove Patent Application Remove Privacy Remove Social Media
article thumbnail

Key Points from the USPTO’s New Guidance on AI Use

IP Intelligence

Patent and Trademark Office (USPTO) recently issued guidance on the use of artificial intelligence (AI), particularly generative AI, in Intellectual Property (IP) practices involving documents filed at the USPTO. Patent claims, for example, require that all claims have a significant contribution by a human inventor.

article thumbnail

SpicyIP Weekly Review (June 28 – July 4)

SpicyIP

In this post , we informed our readers about an announcement from LexisNexis Intellectual Property that LexisNexis Reed Tech will continue to provide patent data and document management services to the USPTO for the next 10 years. Some of these could survive the death of the celebrity, however, the right to privacy was not among them.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2023 IP Resolutions Start with a Review of IP Assets

The IP Law Blog

For trademarks, a good place to start is the company’s marketing and promotional materials, website, mobile app, and social media. Don’t overlook company social media accounts, domain names, and toll-free numbers, which may also serve as potential trademarks. Such inventions may be protectable under federal patent laws.

IP 98
article thumbnail

2023 IP Resolutions Start with a Review of IP Assets

LexBlog IP

For trademarks, a good place to start is the company’s marketing and promotional materials, website, mobile app, and social media. Don’t overlook company social media accounts, domain names, and toll-free numbers, which may also serve as potential trademarks. A special note about customer data.

IP 52
article thumbnail

The Intersection of Artificial Intelligence (AI), Life Sciences, Healthcare, and Intellectual Property (IP)

LexBlog IP

In the intellectual property (IP) space, there has been explosive growth in this area, with AI-based patent filings addressing trending areas, including disease identification and diagnosis, drug discovery, personalized medicine, and clinical trials, among others. The Mayo Client removes all identifying patient information to protect privacy.